Walker Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$599K Buy
1,420
+9
+0.6% +$3.59K 0.3% 63
2026
Q2
$511K Buy
1,411
+10
+0.7% +$3.42K 0.26% 76
2026
Q1
$493K Buy
1,401
+25
+2% +$8.91K 0.27% 73
2025
Q4
$451K Sell
1,376
-50
-4% -$15.9K 0.24% 79
2025
Q3
$402K Sell
1,426
-6
-0.4% -$1.74K 0.23% 83
2025
Q2
$400K Buy
1,432
+11
+0.8% +$3.12K 0.23% 76
2025
Q1
$443K Buy
1,421
+60
+4% +$17.7K 0.27% 66
2024
Q4
$355K Buy
1,361
+27
+2% +$8.01K 0.22% 76
2024
Q3
$430K Sell
1,334
-6
-0.4% -$1.96K 0.27% 66
2024
Q2
$419K Hold
1,340
– – 0.28% 62
2024
Q1
$381K Buy
1,340
+10
+0.8% +$2.93K 0.25% 75
2023
Q4
$383K Buy
+1,330
New +$362K 0.28% 64

Other funds holding AMGN

Walker Asset Management's AMGN Position: Q3 2026 in Review

Walker Asset Management increased its Amgen (AMGN) stake by 0.64% in Q3 2026, buying an estimated $3.59K and bringing the position to 1,420 shares worth $599K. The position accounts for 0.3% of the portfolio, ranked #63.

Walker Asset Management first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. 1,338 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Walker Asset Management held 1,420 shares of Amgen worth $599K as of Q3 2026.
  • Walker Asset Management bought 9 Amgen shares in Q3 2026, an estimated $3.59K.
  • Amgen made up 0.3% of Walker Asset Management's portfolio in Q3 2026, its #63 holding.
  • Walker Asset Management first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Walker Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.